ApoGen increases 2016 Series A funding round to $11 million
Company draws $4 million in additional funding from Merck KGaA's venture capital arm and other investors.
ApoGen secures $7M Series A with Accelerator Corporation
With a $7 million Series A financing round, ApoGen has become the latest startup to enter Accelerator Corporation's syndicate funding and operational support program. It's a strong endorsement from a firm which makes very few investments.
The Role of Consultants in Tackling Healthcare Expenses
To ensure effective cost mitigation, employers can’t wait for the market to adjust — they have to punch first.